NCT00511082
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Department of Clinical Oncology, Prince of Wales Hospital Hong Kong
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT03288974
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Korea University Ansan Hospital Ansan, South Korea
- Hallym University Sacred Heart Hospital Anyang, South Korea
- Soonchunhyang University Hospital Bucheon-si, South Korea
- Inje University Busan Paik Hospital Busan, South Korea
NCT02541383
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- BE-Antwerp-ZNA Stuivenberg Antwerp, Belgium
- AZ St Jan Brugge Oostende AV Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
- UCL Saint-Luc Brussels, Belgium
Completed
CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma
NCT04758767
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- CHU de Nantes - Hôpital Hôtel-Dieu Nantes, France
- CHU Rennes - Pontchaillou Rennes, France
- Gustave Roussy Cancer Center Villejuif, France
- Sarah Cannon London, United Kingdom
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Oncology Institute of Hope and Innovation Glendale, California, United States
- Marin Cancer Center Greenbrae, California, United States
- Asclepes Research Weeki Wachee, Florida, United States
- Oncology Hematology Assoc of Central Illinois, P.C. d.b.a. Illinois CancerCare, P.C. Peoria, Illinois, United States
NCT03700450
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University Medical Center Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany
- Universitätsklinikum Heidelberg Heidelberg, Germany
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany
Completed
Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
NCT02555839
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- LKH Feldkirch, Intern E, Hämatologie Feldkirch, Austria
- Medical University Graz Graz, Austria
- KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Linz, Austria
- Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie Linz, Austria
Completed
Chemotherapy and G-CSF for Mobilization
NCT03442673
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Department for Medical Oncology University Hospital/Inselspital Bern, Switzerland
NCT01163357
- Conditions
- Autologous Hematopoietic Stem Cell Transplant Recipient, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- City of Hope Duarte, California, United States
NCT03748953
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beijing Chaoyang Hospital Capital Medical University Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China